tirzepatide is insulin for diabetes: on track to SURPASS current therapy Frontiers | Tirzepatide against obesity
Description
But how do they compareand which one may be a better fit for your weight loss journey

Apart from those with a history of thyroid cancer, individuals with severe gastrointestinal diseases, such as gastroparesis, should also avoid this medication

The medication allows a surprisingly forgiving window, provided you respect one critical threshold that separates safe early dosing from a nausea-inducing mistake
It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials

Has it been out of the fridge recently
This effect is complementary to the action on the GLP-1 receptor
